Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Xoma Royalty Corporation (XOMA)

Xoma Royalty Corporation (XOMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Xoma Royalty Corporation 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 USA

www.xoma.com Employees: 13 P: 510-204-7200

Sector:

Medical

Description:

XOMA ROYALTY is a biotechnology royalty aggregator. The company acquires the potential future economics associated with pre-commercial therapeutic candidates which have been licensed to pharmaceutical or biotechnology companies. XOMA ROYALTY, formerly known as XOMA Corporation, is based in EMERYVILLE, Calif.

Key Statistics

Overview:

Market Capitalization, $K 294,163
Enterprise Value, $K 309,503
Shares Outstanding, K 11,953
Annual Sales, $ 28,490 K
Annual Net Income, $ -13,820 K
Last Quarter Sales, $ 8,710 K
Last Quarter Net Income, $ -3,970 K
EBIT, $ -39,770 K
EBITDA, $ -39,550 K
60-Month Beta 1.00
% of Insider Shareholders 7.20%
% of Institutional Shareholders 95.92%
Float, K 11,092
% Float 92.80%
Short Volume Ratio 0.57

Growth:

1-Year Return -3.15%
3-Year Return 28.71%
5-Year Return 5.08%
5-Year Revenue Growth 55.09%
5-Year Earnings Growth -1,634.78%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.46 on 03/17/25
Next Earnings Date 05/08/25 [--]
Earnings Per Share ttm -1.99
EPS Growth vs. Prev Qtr -17.95%
EPS Growth vs. Prev Year 6.12%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 10/18/16

XOMA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -25.08%
Return-on-Assets % -9.64%
Profit Margin % -48.51%
Debt/Equity 1.44
Price/Sales 10.13
Price/Cash Flow N/A
Price/Book 3.47
Book Value/Share 6.95
Interest Coverage -0.41
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar